VECT · VectivBio

Acquired Company

Ironwood acquired VectivBio on 12/12/2023 in an all-cash merger at $17.00 per share with aggregate consideration of approximately $1.2 billion.

VectivBio Holding AG, a clinical-stage biopharmaceutical company, focuses on the discovery, development and commercialization of treatments for rare conditions. The company is headquartered in Basel, Switzerland.

AESCHENVORSTADT 36, BASEL, SWITZERLAND, 4051, USA

vectivbio.com

PHARMACEUTICALS

HEALTHCARE

Start AI Chat

Market Cap

1.058B

52 Wk Range

$0.00 - $0.00

Previous Close

$16.85

Open

$16.85

Volume

N/A

Day Range

$16.85 - $16.85

Enterprise Value

N/A

Cash

221.4M

Avg Qtr Burn

N/A

Insider Ownership

4.50%

Institutional Own.

83.80%

Qtr Updated

Mar 31^st 2023